XPHYF News and Press, XPhyto Therapeutics Corp From 04/03/23

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOVER, BC / ACCESSWIRE / April 3, 2023 / BioNxt Solutions Inc. (" BioNxt " or the " Company ") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) announces that, further to its news release of March 27, 2023,...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / March 27, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), is pleased to announce that further to its news release of March...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / March 10, 2023 / BioNxt Solutions Inc. (" BioNxt " or the " Company ") (CSE:BNXT)(FSE:4XT) is pleased to announce a non-brokered private placement of up to 5,000,00...

VANCOUVER, BC / ACCESSWIRE / March 7, 2023 / BioNxt Solutions Inc. (" BioNxt " or the " Company ") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to report that it has signed a definitive technology transfer and patent assignment agreement (the "Agreement") to acquire certain technology and intelle...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / March 2, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:4XT), is pleased to announce that it has entered into an agreement wit...

VANCOUVER, BC / ACCESSWIRE / March 1, 2023 / BioNxt Solutions Inc. (" BioNxt " or the " Company ") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to report that it has executed an agreement to carry out its comparative drug absorption study for the Company's transdermal ("TDS") Rotigotine patch for...

VANCOUVER, BC / ACCESSWIRE / February 13, 2023 / BioNxt Solutions Inc. (" BioNxt " or the " Company ") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT) is pleased to report an update on its commercialization plan for its transdermal Rotigotine patch for the treatment of Parkinson's disease ("PD"). The Company's R...

BioNxt Solutions (CSE: BNXT) (OTCQB: XPHYF) (FSE: 4XT) today announced that it has signed a non-binding term sheet for the acquisition of certain intellectual property assets and rights related to a novel solid oral drug dosage form coating delivery technology. “BioNxt is extremely please...

BioNxt Solutions ( OTCQB:XPHYF ) has signed a non-binding term sheet for the acquisition of certain intellectual property assets and rights related to a novel solid oral drug dosage form coating delivery technology. "BioNxt is extremely pleased to expand our technology portfolio with ...

VANCOUVER, BC / ACCESSWIRE / December 12, 2022 / BioNxt Solutions Inc. (" BioNxt " or the " Company ") (CSE:XPHY)(OTC:XPHYF)(FSE:4XT) is pleased to report that it has signed a non-binding term sheet (the "Term Sheet") for the acquisition of certain intellectual property assets and rights related...